[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2023, "totalPay": 539694, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2023, "totalPay": 212675, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2023, "totalPay": 372181, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 62, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 538585, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.01, "open": 1.02, "dayLow": 0.96, "dayHigh": 1.02, "regularMarketPreviousClose": 1.01, "regularMarketOpen": 1.02, "regularMarketDayLow": 0.96, "regularMarketDayHigh": 1.02, "payoutRatio": 0.0, "beta": 0.67, "forwardPE": -3.2580645, "volume": 124516, "regularMarketVolume": 124516, "averageVolume": 246038, "averageVolume10days": 208630, "averageDailyVolume10Day": 208630, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 83435088, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 3.12, "fiftyDayAverage": 1.10246, "twoHundredDayAverage": 1.62229, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 53013584, "profitMargins": 0.0, "floatShares": 78707369, "sharesOutstanding": 82609000, "sharesShort": 1845780, "sharesShortPriorMonth": 1869568, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0223, "heldPercentInsiders": 0.04003, "heldPercentInstitutions": 0.102110006, "shortRatio": 7.85, "shortPercentOfFloat": 0.0232, "impliedSharesOutstanding": 86488496, "bookValue": 0.299, "priceToBook": 3.3779263, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -36677300, "trailingEps": -0.37, "forwardEps": -0.31, "enterpriseToEbitda": -1.322, "52WeekChange": -0.42613637, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 1.01, "targetHighPrice": 10.02383, "targetLowPrice": 8.26762, "targetMeanPrice": 8.979816, "targetMedianPrice": 8.813908, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 30580028, "totalCashPerShare": 0.37, "ebitda": -40114544, "totalDebt": 158532, "quickRatio": 4.414, "currentRatio": 4.518, "debtToEquity": 0.641, "returnOnAssets": -0.73429, "returnOnEquity": -1.3847001, "freeCashflow": -11860443, "operatingCashflow": -25060868, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "earningsTimestampStart": 1745265600, "earningsTimestampEnd": 1746129600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.37, "epsForward": -0.31, "epsCurrentYear": -0.495, "priceEpsCurrentYear": -2.040404, "fiftyDayAverageChange": -0.09246004, "fiftyDayAverageChangePercent": -0.08386702, "twoHundredDayAverageChange": -0.61229, "twoHundredDayAverageChangePercent": -0.3774233, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-10", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1744934049, "regularMarketTime": 1744920001, "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.01, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1547562600000, "postMarketChangePercent": -4.20792, "postMarketPrice": 0.9675, "postMarketChange": -0.0425, "regularMarketChange": 0.0, "regularMarketDayRange": "0.96 - 1.02", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 246038, "fiftyTwoWeekLowChange": 0.23899996, "fiftyTwoWeekLowChangePercent": 0.30998698, "fiftyTwoWeekRange": "0.771 - 3.12", "fiftyTwoWeekHighChange": -2.11, "fiftyTwoWeekHighChangePercent": -0.67628205, "fiftyTwoWeekChangePercent": -42.613636, "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]